Showing results (231-240 of 299) with videos related to

Sort By:
Pageof 30
Cancer|July 1, 1993
Single-agent carboplatinum for advanced seminoma. A phase II studyH J Schmoll, A Harstrick, C Bokemeyer, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
A pilot study of rapidly alternating epirubicin/dacarbazine and ifosfamide as first-line therapy for metastatic soft-tissue sarcoma in adultsA Harstrick, C Bokemeyer, H J Schmoll, et al.
Clinical Immunology and Immunopathology|October 1, 1992
Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disordersU B Wandl, M Nagel-Hiemke, D May, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1992
Treatment of high-risk, nonseminomatous testicular cancer with cisplatin, ifosfamide and bleomycin: long-term resultsU B Wandl, K Günzel, R Kath, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 1999
First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: A multivariate and matched-pair analysisC Bokemeyer, C Kollmannsberger, C Meisner, et al.
Journal of Cancer Research and Clinical Oncology|August 10, 2000
Type and position of promoter elements in retroviral vectors have substantial effects on the expression level of an enhanced green fluorescent protein reporter geneM Flasshove, W Bardenheuer, A Schneider, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|January 1, 1994
[Surgery of locally advanced non-small-cell bronchial cancer after intensive preoperative chemo-/radiotherapy]G Stamatis, H Wilke, W Eberhardt, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1990
[DL-1,2-bis(2-hydroxyphenyl)ethylenediamine]dichloroplatinum(II), a new compound for the therapy of ovarian cancerR Müller, R Gust, G Bernhardt, et al.
Pageof 30